Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NUT family member 2H, pseudogene (NUTM2HP)
- Target
- NUTM2HP
- Molecular classification
- Other, Pseudogene
01
Overview
NUT family member 2H, pseudogene (NUTM2HP), is classified as a pseudogene, meaning it resembles a functional gene but is generally not transcribed into a functional protein[1][5]. There is no evidence to suggest that NUTM2HP has a direct biological function, is involved in disease, or serves as a therapeutic drug target. No drugs are known to interact with this locus, and it is not considered a biomarker or molecular target. Its aliases include FAM22HP and NUTMHP. As a pseudogene, it does not fall into major actionable classes such as receptor, enzyme, or transporter and is not relevant for therapeutic intervention.
- Other names
- FAM22HPNUTMHP
Beyond the preview
Go deeper on NUT family member 2H, pseudogene (NUTM2HP).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NUT family member 2H, pseudogene (NUTM2HP).